Literature DB >> 7390481

Duchenne muscular dystrophy: data from family studies.

G A Danieli, M L Mostacciuolo, G Pilotto, C Angelini, A Bonfante.   

Abstract

In an extensive epidemiological survey of Duchenne muscular dystrophy carried out in Venetia (Italy) the incidence was found to be 28.2 X 10(-5) and female gamete mutation rate was estimated by the direct method between 61 and 35 X 10(-6). The percentage of isolated cases was 0.54. Indirect and direct estimates of this proportion suggest, however, that only a minor fraction arises from maternal mutation (from 0.11 to 0.18 of the total number of cases). Studies on pedigrees collected in the course of the survey indicate that there is a higher frequency of Duchenne carrier females than normal females in affected sibships. Additional evidence supporting the hypothesis of a reproductive heterozygote advantage and gametic selection is reported.

Entities:  

Mesh:

Year:  1980        PMID: 7390481     DOI: 10.1007/bf00279050

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  The rate of spontaneous mutation of a human gene. 1935.

Authors:  J B S Haldane
Journal:  J Genet       Date:  2004-12       Impact factor: 1.166

2.  Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds.

Authors:  F E STEPHENS; F H TYLER
Journal:  Am J Hum Genet       Date:  1951-06       Impact factor: 11.025

Review 3.  Pathogenesis of muscular dystrophies.

Authors:  L P Rowland
Journal:  Arch Neurol       Date:  1976-05

4.  A probable sex difference in some mutation rates.

Authors:  F Vogel
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

5.  The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne.

Authors:  D Gardner-Medwin; R J Pennington; J N Walton
Journal:  J Neurol Sci       Date:  1971-08       Impact factor: 3.181

6.  The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease.

Authors:  U Francke; J Felsenstein; S M Gartler; B R Migeon; J Dancis; J E Seegmiller; F Bakay; W L Nyhan
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

7.  Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.

Authors:  M Zatz; O Frota-Pessoa; J A Levy; C A Peres
Journal:  J Genet Hum       Date:  1976-06

8.  Chemical compositional studies of erythrocyte membranes in Duchenne muscular dystrophy.

Authors:  D V Godin; M A Bridges; P J MacLeod
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-05

9.  Rheologic properties of erythrocytes in Duchenne muscular dystrophy.

Authors:  W Tillmann; H G Lenard; D Wagner; H Dönges; W Schröter
Journal:  Pediatr Res       Date:  1979-03       Impact factor: 3.756

10.  The laboratory diagnosis of the carrier state for classic hemophilia.

Authors:  O D Ratnoff; P K Jones
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

View more
  10 in total

1.  On the estimation of the proportion of sporadic cases in Duchenne muscular dystrophy.

Authors:  G A Danieli; G Barbujani
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

2.  On the power to detect differences between male and female mutation rates for Duchenne muscular dystrophy, using classical segregation analysis and restriction fragment length polymorphisms.

Authors:  E R Karel; G J te Meerman; L P Ten Kate
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

Review 3.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Duchenne muscular dystrophy. Frequency of sporadic cases.

Authors:  G A Danieli; G Barbujani
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Epidemiology of Duchenne muscular dystrophy in the province of Turin.

Authors:  A Bertolotto; M De Marchi; C Doriguzzi; T Mongini; C Monnier; L Palmucci; D Schiffer; L Verzé
Journal:  Ital J Neurol Sci       Date:  1981-01

6.  Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases.

Authors:  G Barbujani; A Russo; G A Danieli; A W Spiegler; J Borkowska; I H Petrusewicz
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

7.  The genetic status of mothers of isolated cases of Duchenne muscular dystrophy.

Authors:  R J Lane; M Robinow; A D Roses
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

8.  Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands.

Authors:  A J van Essen; H F Busch; G J te Meerman; L P ten Kate
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

9.  The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.

Authors:  Erik K Henricson; R Ted Abresch; Avital Cnaan; Fengming Hu; Tina Duong; Adrienne Arrieta; Jay Han; Diana M Escolar; Julaine M Florence; Paula R Clemens; Eric P Hoffman; Craig M McDonald
Journal:  Muscle Nerve       Date:  2013-05-06       Impact factor: 3.217

Review 10.  Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.

Authors:  Salvatore Crisafulli; Janet Sultana; Andrea Fontana; Francesco Salvo; Sonia Messina; Gianluca Trifirò
Journal:  Orphanet J Rare Dis       Date:  2020-06-05       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.